Game-changing CAR-T therapy made inside the body could slash costs and save lives
NCT ID NCT07383233
First seen Feb 03, 2026 · Last updated Apr 30, 2026 · Updated 18 times
Summary
This early-stage study tests a new approach to CAR-T cell therapy for people with relapsed or hard-to-treat B-cell leukemia and lymphoma. Instead of making the CAR-T cells in a lab, the treatment creates them inside the patient's body, which could lower costs and make therapy faster and more accessible. The study will enroll 18 participants to check safety and how well the treatment works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.